Question 1

What is complete androgen insensitivity syndrome?

Accepted Answer

Complete androgen insensitivity syndrome (CAIS) is a form of disorder of sex development in which individuals with a 46,XY karyotype develop typically female external genitalia. Despite normal testicular development, the body does not respond to androgens at expected levels, leading to undescended testes and an absence of masculine features. The condition is rare, affecting roughly 1 to 9 per million people. It is often identified during adolescence when differences in sexual development, such as primary amenorrhea, become apparent.

Question 2

What are the symptoms of complete androgen insensitivity syndrome?

Accepted Answer

Individuals with complete androgen insensitivity syndrome present with female external genitalia despite having a 46,XY chromosomal makeup. Due to the body's inability to respond to androgens, features such as undescended testes and a lack of typical male secondary sexual characteristics may be observed. Clinical detection often occurs during evaluations for inguinal hernias or delayed puberty, and findings can include typical female breast development with sparse or absent pubic hair. Not all individuals experience all features, and severity varies considerably.

Question 3

What causes complete androgen insensitivity syndrome?

Accepted Answer

The precise genetic basis of complete androgen insensitivity syndrome is under investigation. The condition arises because the body is unable to respond appropriately to androgens, which are critical for male sexual differentiation. As the specific inheritance pattern has not been clearly defined from available data, the underlying mechanism remains a topic of continued research. Families encountering this diagnosis are encouraged to seek genetic counseling to discuss potential implications and recurrence risks.

Question 4

How rare is complete androgen insensitivity syndrome?

Accepted Answer

complete androgen insensitivity syndrome is classified as rare. The estimated prevalence is approximately 1-9 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 5

How is complete androgen insensitivity syndrome diagnosed?

Accepted Answer

Diagnosis begins with a thorough clinical evaluation that includes a review of developmental history and physical findings. Molecular genetic testing, while useful in supporting the diagnosis by assessing androgen signaling, is complemented by hormonal studies and imaging since the precise genetic marker is still under investigation. Because symptoms can overlap with other conditions, comprehensive diagnostic testing is essential to confirm the diagnosis of complete androgen insensitivity syndrome.

Question 6

Are there treatments for complete androgen insensitivity syndrome?

Accepted Answer

Currently, management focuses on supportive care and symptom management, as there are no treatments specifically approved for complete androgen insensitivity syndrome. Individualized care may include hormonal management, surgical intervention such as gonadectomy to mitigate future complications, and psychological support to address the unique challenges related to the condition. A multidisciplinary team—often including endocrinologists, surgeons, and mental health professionals—plays a key role in developing a tailored treatment plan. Patients should discuss treatment options with their healthcare team to determine the most appropriate approach and consider genetic counseling for family planning.

Question 7

Are there clinical trials for complete androgen insensitivity syndrome?

Accepted Answer

Yes, there are currently 2 active clinical trials for complete androgen insensitivity syndrome registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 8

What complications can arise from complete androgen insensitivity syndrome?

Accepted Answer

Individuals with complete androgen insensitivity syndrome may face complications such as undescended testes, which can lead to an increased risk of testicular cancer if not managed properly. Additionally, there can be concerns regarding bone health due to hormone levels. Regular check-ups with healthcare providers are important to monitor these risks and ensure overall health.

Question 9

How does complete androgen insensitivity syndrome affect daily life and management?

Accepted Answer

Living with complete androgen insensitivity syndrome can involve managing unique challenges, such as addressing feelings about gender identity and physical development. Many individuals may require support from healthcare professionals, including mental health support, to navigate these issues. Regular follow-ups with a multidisciplinary team can help tailor care to individual needs.

Question 10

What is the prognosis for individuals with complete androgen insensitivity syndrome?

Accepted Answer

The prognosis for individuals with complete androgen insensitivity syndrome is generally positive, with many achieving a good quality of life. While there can be implications for bone health and psychological well-being, modern care approaches have improved outcomes significantly. Each person's experience may vary, so ongoing support and monitoring are essential.

Question 11

What should families consider regarding family planning with complete androgen insensitivity syndrome?

Accepted Answer

Families dealing with complete androgen insensitivity syndrome should consider genetic counseling to understand the implications for family planning. This can help assess the risk of recurrence in future pregnancies and provide support in making informed decisions. Discussing these topics with healthcare providers can help families navigate their options.

Kisho

complete androgen insensitivity syndrome

Overview

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Recent Publications

Latest News & Developments

Current clinical care for women with complete androgen insensitivity syndrome across the European reference network on rare endocrine conditions.

complete androgen insensitivity syndrome

Overview

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is complete androgen insensitivity syndrome?

What are the symptoms of complete androgen insensitivity syndrome?

What causes complete androgen insensitivity syndrome?

How rare is complete androgen insensitivity syndrome?

How is complete androgen insensitivity syndrome diagnosed?

Are there treatments for complete androgen insensitivity syndrome?

Are there clinical trials for complete androgen insensitivity syndrome?

What complications can arise from complete androgen insensitivity syndrome?

How does complete androgen insensitivity syndrome affect daily life and management?

What is the prognosis for individuals with complete androgen insensitivity syndrome?

What should families consider regarding family planning with complete androgen insensitivity syndrome?

Recent Publications

Latest News & Developments

Current clinical care for women with complete androgen insensitivity syndrome across the European reference network on rare endocrine conditions.